Product
Topical corticosteroid
3 clinical trials
2 indications
Indication
Atopic DermatitisIndication
Acanthamoeba KeratitisClinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic DermatitisStatus: Active (not recruiting), Estimated PCD: 2022-04-24
Clinical trial
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, CyclosporineStatus: Completed, Estimated PCD: 2019-11-25